by Combat Cancer | Oct 19, 2023 | News
Understanding Ovarian Cancer: Long Waits, Inequalities, and the Path Forward Ovarian cancer, often called the “silent killer,” poses significant challenges in terms of diagnosis and treatment. The 2022 Pathfinder Report from “Target Ovarian...
by Combat Cancer | Oct 12, 2023 | News
On the 10th of October 2023, the world came together to observe World Mental Health Day. It’s a day dedicated to discussing mental health openly and emphasising its significance, whilst also letting individuals know that seeking help is not a sign of weakness,...
by Combat Cancer | Oct 4, 2023 | News
Bladder cancer, often referred to as the “Cinderella of cancers,” is a prevalent but underestimated health issue in Europe. In this blog, we will shed light on the critical aspects of bladder cancer, including its prevalence, the lack of awareness, and the...
by Combat Cancer | Jul 20, 2023 | News
Last Saturday, thousands of people around the UK took part in Pancreatic Cancer UK’s Big Step Forward. Simply by going for a walk, they raised over £200,000 for pancreatic cancer research and specialist nurses. They were also raising awareness of a disease that is the...
by Combat Cancer | Jul 7, 2023 | News
We are excited to announce the proposed BCG-Unresponsive Trial – Combat HIVEC HEAT – in partnership with Leicester University Clinical Trials Unit. This is a phase 3, multi-centre, single-arm interventional trial of HIVEC® with Medac mitomycin C + maintenance for...
by Combat Cancer | Dec 1, 2022 | News
Press release, 1 December 2022 Combat Medical is pleased to announce the results of the HIVEC I phase 3 randomised controlled trial, published in European Urology Oncology on 23 November 2022. As with this year’s HIVEC II publication, this short-term regimen shows...
Recent Comments